JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M407358200 on August 19, 2004

J. Biol. Chem., Vol. 279, Issue 46, 48135-48142, November 12, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/46/48135    most recent
M407358200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gentile, M. T.
Right arrow Articles by Lembo, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gentile, M. T.
Right arrow Articles by Lembo, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mechanisms of Soluble {beta}-Amyloid Impairment of Endothelial Function*

Maria Teresa Gentile{ddagger}||, Carmine Vecchione{ddagger}, Angelo Maffei{ddagger}, Alessandra Aretini{ddagger}, Gennaro Marino{ddagger}, Roberta Poulet{ddagger}, Loredana Capobianco{ddagger}, Giulio Selvetella{ddagger}, and Giuseppe Lembo{ddagger}§¶||

From the {ddagger}Department of Angio-Cardio-Neurology, IRCCS "NEUROMED," Pozzilli (IS) and the §Department of Experimental Medicine and Pathology, "La Sapienza" University, Rome 86077, Italy and the ||Excellence Centre for Cardiovascular Disease, Second University of Naples, Naples 80100, Rome

Alzheimer's disease (AD) has been recently associated with vascular risk factors. {beta}-amyloid peptides (A{beta}P), the main component of senile plaques typical of AD, circulate in soluble globular form in bloodstream. Interestingly, A{beta}P is able to induce endothelial dysfunction, and this effect may represent the link between vascular and neuronal pathophysiological factors involved in AD. We aimed to clarify the molecular mechanisms underlying globular A{beta}P-induced vascular toxicity. Using several methodological approaches, we have observed that in vascular tissues globular A{beta}P is unable to induce oxidative stress, one of the mechanisms hypothesized involved in {beta}-amyloid toxicity. More important, we have demonstrated that globular A{beta}P is able to localize on vascular endothelium, where it inhibits eNOS enzymatic activity. In particular, A{beta}P enhances eNOS phosphorylation on threonine 495 and serine 116 and reduces acetylcholine-induced phosphorylation on serine 1177. Such an effect depends on a PKC signaling pathway, as suggested by its phosphorylation on serine 660. In fact, selective inhibition of the calcium-dependent group of PKC is able to rescue {beta}-amyloid-induced alteration of eNOS phosphorylation, NO production, and endothelial vasorelaxation. The activation of these Ca2+-dependent pathways is probably due to the ability of A{beta}P to evoke Ca2+ leakage from inositol 1,4,5-triphosphate receptors on endoplasmic reticulum. Our data demonstrate that globular A{beta}P-induced endothelial NO dysfunction can be attributed to an alteration of intracellular Ca2+ homeostasis, which could lead to the activation of calcium-dependent group of PKC with a consequent change of the eNOS phosphorylation pattern. These mechanisms could contribute to shed further light on the toxic effect of {beta}-amyloid in vascular tissues.


Received for publication, July 1, 2004 , and in revised form, July 29, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: IRCCS Neuromed, Località Camerelle, 86077 Pozzilli (IS), Italy. Tel.: 39-0865-915244; Fax: 39-0865-927575; E-mail: lembo{at}neuromed.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. Herrmann, S. M. Soares, L. O. Lerman, and A. Lerman
Potential Role of the Ubiquitin-Proteasome System in Atherosclerosis: Aspects of a Protein Quality Disease
J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2003 - 2010.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. T. Gentile, C. Vecchione, G. Marino, A. Aretini, A. Di Pardo, G. Antenucci, A. Maffei, G. Cifelli, L. Iorio, A. Landolfi, et al.
Resistin Impairs Insulin-Evoked Vasodilation
Diabetes, March 1, 2008; 57(3): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Long, L. G. Cook, S. L. Hamilton, G.-Y. Wu, and B. M. Mitchell
FK506 Binding Protein 12/12.6 Depletion Increases Endothelial Nitric Oxide Synthase Threonine 495 Phosphorylation and Blood Pressure
Hypertension, March 1, 2007; 49(3): 569 - 576.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Vecchione, E. Patrucco, G. Marino, L. Barberis, R. Poulet, A. Aretini, A. Maffei, M. T. Gentile, M. Storto, O. Azzolino, et al.
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3K{gamma}
J. Exp. Med., April 18, 2005; 201(8): 1217 - 1228.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.